Available at: Administration USFD.OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S
Wegovy injection is approved alongside diet and exercise to reduce excess body weight in adults and in children aged 12 and older with obesity, to lower the risk of serious heart events (heart attack, stroke, or cardiovascular death) in adults with obesity or overweight who also have established heart disease, and for treatment of a liver condition called MASH (metabolic dysfunction-associated steatohepatitis, formerly called NASH) with moderate-to-advanced scarring in adults
The Impact of Semaglutide on Eye Health: Balancing Benefits and Risks The diabetes drug semaglutid e has been making headline news ever since the medication received FDA approval for blood sugar control and obesity treatment
What's interesting is that it seems to work as a stabilizer rather than a simple on/off switch
Researchers examined data from more than 100,000 individuals with diabetes and found that users of GLP-1 receptor agonists, including Ozempic, may face a higher risk of developing NAION compared to those using other diabetes medications